2Jefford M, Maraskovsky E, Cebon J, et al. The use of dendritic ceils in cancer therapy. Lancet Oncol, 2001,2(6):343.
二级参考文献24
1Becker Y.Dendritic cell activity against primary tumors:an overview.In Vivo.1993,7(3):187
2Ishigami S,Aikou T,Natsugoe S,et al.Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer[J].Oncology,1998,55(1):65
3Lissoni P,Vigore L,Ferranti R,et al.Circulating dendritic cells in early and advanced cancer patients:diminished percent in the metastatic disease[J].J Biol Regul Homeost Agents,1999,13(4):216
4Gabrilovich DI,Corak J,Ciernik IF,et al.Decreased antigen presentation bydendritic cells in patients with breast cancer[J].Clin Cancer Res,1997,3(3):483
5Troy A,Davidson PJ,Atkinson CH,et al.CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated[J].J Urol,1999,16(6):1962
6Fearon DT,Locksley RM.The instructive role of innate immunity in the acquired immune response[J].Science,1996,272(5258):50
8Steinman RM,.Dendritic cells and immune-based therapies[J].Exp Hematol,1996,24(8):859
9Heufler C,Koch F,Stanzl U,et al.Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells[J].Eur J Immunol,1996,26(3):659
10Adema GJ,Hartgers F,Verstraten R,et al.A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells[J].Nature,1997,387(6634):713